Industries
Biomanufacturing infrastructure for every serious life science market.
CDMO Network Europe helps sponsors route programs across biopharma, biotech, diagnostics, animal health, food biotech, industrial biology, public sector programs, and emerging hybrid markets.
The industries are different, but the outsourcing problem is similar: find the right technical capability, quality level, geography, scale, analytics, timeline, and partner fit without wasting months in mismatched conversations.
Pharma-grade logic.
Quality, comparability, release, and CMC discipline for regulated therapeutic programs.
Biotech speed.
Fast routing for venture-backed, translational, platform, and proof-of-concept companies.
Industrial scale.
Fermentation, enzymes, ingredients, food proteins, and applied biology at practical scale.
Edge coverage.
Animal health, diagnostics, exosomes, phage, microbiome, public sector, and hybrid platforms.
Primary Markets
Industries served by CDMO Network Europe.
Each market needs different routing logic. A monoclonal antibody sponsor, a veterinary vaccine company, an exosome platform, and a food protein startup may all need CDMOs, but they do not need the same CDMO path.
Biopharmaceuticals
Therapeutic biologics, clinical-stage drug developers, commercial pharma programs, lifecycle support, and GMP supply.
Biotechnology
Platform companies, venture-backed innovators, translational programs, early proof-of-concept, and first external manufacturing routes.
Cell & Gene Therapy
Advanced therapy sponsors needing viral vectors, cell processing, plasmids, analytics, cryopreservation, and GMP clinical execution.
Vaccines & Infectious Disease
Vaccine developers, pandemic preparedness, public-private programs, antigens, viral platforms, aseptic fill, and clinical supply.
Diagnostics & Life Science Tools
IVD companies, reagent manufacturers, assay developers, research tool suppliers, biomarker platforms, and critical raw material programs.
Microbiome & Live Biotherapeutics
Live biological products, probiotics, anaerobes, strain banking, formulation, lyophilization, spray drying, and release testing.
Food, Nutrition & Alternative Proteins
Precision fermentation, recombinant food proteins, enzymes, nutritional ingredients, GRAS-oriented programs, and food-grade production.
Animal Health & Veterinary
Veterinary vaccines, animal biologics, livestock products, companion animal therapeutics, veterinary diagnostics, and species-specific biologics.
Industrial Biotech & Enzymes
Enzyme manufacturing, specialty proteins, bio-based inputs, fermentation-derived materials, industrial microbes, and applied synthetic biology.
Exosomes, Nanomedicine & Delivery
Extracellular vesicles, engineered particles, LNP programs, liposomes, nanoparticle analytics, drug delivery, and sterile particle formats.
Public Sector & Institutional Programs
Government, university, hospital, defense-adjacent, pandemic preparedness, public health, and institutional translational manufacturing needs.
Emerging & Hybrid Applications
Programs that cross categories: biologic-device hybrids, phage, cell-free systems, synthetic biology, radiolabeled biologics, and unusual CMC.
Deeper Industry Coverage
Where the network model matters most.
Many CDMO searches fail because the sponsor defines the industry too broadly. We structure industry routing by biological product type, regulatory path, application, end market, and operational reality.
Therapeutic biopharma
Advanced therapeutic industries
Diagnostics, tools & testing
Food, ag & environmental biology
Veterinary and animal industries
Industrial and specialty biotechnology
Industry fit is not the same as CDMO fit.
A company’s market describes the destination. CDMO routing defines the route: product class, stage, quality level, geography, analytics, formulation, manufacturing platform, and commercial constraints.